Untreated (n = 49) | ART Treated (n = 49) | |||
---|---|---|---|---|
Standardized β coefficients | P | Standardized β coefficients | P | |
Clinical characteristics: | ||||
Age (years) | 0.180 | 0.21 | 0.290 | 0.04 |
Gender, male | 0.137 | 0.34 | 0.110 | 0.94 |
Current smoker, | 0.129 | 0.39 | −0.182 | 0.24 |
Current CD4+ T cell count (cells/μl) | 0.035 | 0.81 | 0.084 | 0.57 |
Nadir CD4+ T cell count (cells/μl) | −0.081 | 0.58 | 0.087 | 0.55 |
HIV-RNA (103 copies/ml) | −0.010 | 0.94 | NA | NA |
HIV duration | 0.078 | 0.59 | 0.070 | 0.64 |
Class of ART | ||||
NRTI containing (n = 44) | NA | NA | 0.043 | 0.78 |
NNRTI containing (n = 22) | NA | NA | 0.135 | 0.38 |
PI containing (n = 23) | NA | NA | 0.145 | 0.34 |
II containing (n = 4) | NA | NA | −0.024 | 0.87 |
Abacavir containing (n = 16) | NA | NA | −0.126 | 0.41 |
Standard coagulation | ||||
D-dimer | 0.051 | 0.74 | 0.209 | 0.16 |
Fibrinogen | 0.091 | 0.55 | 0.183 | 0.24 |
APTT | 0.117 | 0.43 | 0.171 | 0.27 |
Coagulation factors 2–7-10 | 0.043 | 0.77 | 0.032 | 0.83 |
Platelet aggregation (Multiplate): | ||||
ADP test (Units) | −0.074 | 0.62 | −0.177 | 0.23 |
ASPI test (Units) | −0.156 | 0.29 | −0.243 | 0.10 |
COL test (Units) | −0.080 | 0.59 | −0.211 | 0.15 |
TRAP test (Units) | −0.119 | 0.42 | −0.220 | 0.13 |
Hypocoagulable in ≥2/4 tests | 0.007 | 0.97 | 0.147 | 0.32 |
Hypercoagulable in ≥2/4 tests | −0.172 | 0.24 | NA | NA |
Markers of Microbial translocation and inflammation: | ||||
sCD14 (ρg/ml) | 0.454 | 0.001 | −0.157 | 0.28 |
LPS (ρg/ml) | −0.019 | 0.90 | 0.047 | 0.75 |
hsCRP | −0.016 | 0.92 | 0.028 | 0.37 |